1 Beall D, Bywaters EG, Belsey RH, et al. Crush Injury with Renal Failure. Br Med J 1941;1:432–4.
2 Kellum JA, Levin N, Bouman C, et al. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 2002;8. doi:10.1097/00075198-200212000-00005
3 Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8. doi:10.1186/cc2872
4 Mehta RL, Kellum JA, Shah S V, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11. doi:10.1186/cc5713
5 Section 2: AKI Definition. Kidney Int Suppl 2012;2:19–36. doi:10.1038/kisup.2011.32
6 Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365–70. doi:10.1681/ASN.2004090740
7 Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004;15:1597–605.
8 Hoste EAJ, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 2015;41:1411–23. doi:10.1007/s00134-015-3934-7
9 Luo X, Jiang L, Du B, et al. A comparison of different diagnostic criteria of acute kidney injury in critically ill patients. Crit Care 2014;18:R144. doi:10.1186/cc13977
10 Nisula S, Kaukonen K-M, Vaara ST, et al. Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study. Intensive Care Med 2013;39:420–8. doi:10.1007/s00134-012- 2796-5
11 Fujii T, Uchino S, Doi K, et al. Diagnosis, management, and prognosis of patients with acute kidney injury in Japanese intensive care units: The JAKID study. J Crit Care 2018;47:185–91. doi:10.1016/j.jcrc.2018.07.007
12 Fujii T, Uchino S, Takinami M, et al. Validation of the Kidney Disease Improving Global Outcomes criteria for AKI and comparison of three criteria in hospitalized patients. Clin J Am Soc Nephrol 2014;9:848–54. doi:10.2215/CJN.09530913
13 Bouchard J, Acharya A, Cerda J, et al. A Prospective International Multicenter Study of AKI in the Intensive Care Unit. Clin J Am Soc Nephrol 2015;10:1324 LP-1331.http://cjasn.asnjournals.org/content/10/8/1324.abstract
14 Iwagami M, Yasunaga H, Noiri E, et al. Current state of continuous renal replacement therapy for acute kidney injury in Japanese intensive care units in 2011: analysis of a national administrative database. Nephrol Dial Transplant 2015;30:988–95. doi:10.1093/ndt/gfv069
15 Gaudry S, Hajage D, Schortgen F, et al. Initiation Strategies for Renal- Replacement Therapy in the Intensive Care Unit. N Engl J Med 2016;375:122–33. doi:10.1056/NEJMoa1603017
16 Zarbock A, Kellum JA, Schmidt C, et al. Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial. JAMA 2016;315:2190–9. doi:10.1001/jama.2016.5828
17 Waikar SS, Bonventre J V. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 2009;20:672–9. doi:10.1681/ASN.2008070669
18 Doi K, Yuen PST, Eisner C, et al. Reduced production of creatinine limits its use as marker of kidney injury in sepsis. J Am Soc Nephrol 2009;20:1217–21. doi:10.1681/ASN.2008060617
19 Haase M, Bellomo R, Devarajan P, et al. Accuracy of neutrophil gelatinase- associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009;54:1012–24. doi:10.1053/j.ajkd.2009.07.020
20 Susantitaphong P, Siribamrungwong M, Doi K, et al. Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis. Am J Kidney Dis 2013;61:430–9. doi:10.1053/j.ajkd.2012.10.016
21 Mishra J, Mori K, Ma Q, et al. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004;24:307–15. doi:10.1159/000078452
22 Mishra J, Ma Q, Prada A, et al. Identification of Neutrophil Gelatinase- Associated Lipocalin as a Novel Early Urinary Biomarker for Ischemic Renal Injury. J Am Soc Nephrol 2003;14:2534 LP- 2543.https://jasn.asnjournals.org/content/14/10/2534.abstract
23 Supavekin S, Zhang W, Kucherlapati R, et al. Differential gene expression following early renal ischemia/reperfusion. Kidney Int 2003;63:1714–24. doi:10.1046/j.1523-1755.2003.00928.x
24 Schmidt-Ott KM, Mori K, Kalandadze A, et al. Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens 2006;15:442–9. doi:10.1097/01.mnh.0000232886.81142.58
25 Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of lipocalin-siderophore- iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005;115:610–21. doi:10.1172/JCI23056
26 Hvidberg V, Jacobsen C, Strong RK, et al. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett 2005;579:773–7. doi:10.1016/j.febslet.2004.12.031
27 Maatman RGHJ, van de Westerlo EMA, van Kuppevelt THMSM, et al. Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. Biochem J 1992;288:285 LP- 290.http://www.biochemj.org/content/288/1/285.abstract
28 Maatman RGHJ, Van Kuppevelt THMSM, Veerkamp JH. Two types of fatty acid-binding protein in human kidney. Isolation, characterization and localization. Biochem J 1991;273:759 LP- 766.http://www.biochemj.org/content/273/3/759.abstract
29 Matsui K, Kamijo-Ikemorif A, Sugaya T, et al. Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity. Am J Pathol 2011;178:1021–32. doi:10.1016/j.ajpath.2010.12.002
30 Yamamoto T, Noiri E, Ono Y, et al. Renal L-type fatty acid--binding protein in acute ischemic injury. J Am Soc Nephrol 2007;18:2894–902. doi:10.1681/ASN.2007010097
31 Negishi K, Noiri E, Maeda R, et al. Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury. Kidney Int 2008;73:1374–84. doi:10.1038/ki.2008.106
32 Malhotra R, Siew ED. Biomarkers for the Early Detection and Prognosis of Acute Kidney Injury. Clin J Am Soc Nephrol 2017;12:149–73. doi:10.2215/CJN.01300216
33 Endre ZH, Pickering JW, Walker RJ, et al. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int 2011;79:1119–30. doi:10.1038/ki.2010.555
34 Klein SJ, Brandtner AK, Lehner GF, et al. Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta- analysis. Intensive Care Med 2018;44:323–36. doi:10.1007/s00134-018-5126-8
35 Pike F, Murugan R, Keener C, et al. Biomarker Enhanced Risk Prediction for Adverse Outcomes in Critically Ill Patients Receiving RRT. Clin J Am Soc Nephrol 2015;10:1332 LP-1339.http://cjasn.asnjournals.org/content/10/8/1332.abstract
36 Parikh CR, Thiessen-Philbrook H, Garg AX, et al. Performance of Kidney Injury Molecule-1 and Liver Fatty Acid-Binding Protein and Combined Biomarkers of AKI after Cardiac Surgery. Clin J Am Soc Nephrol 2013;8:1079 LP- 1088.http://cjasn.asnjournals.org/content/8/7/1079.abstract
37 Murugan R, for the Biological Markers for Recovery of Kidney (BioMaRK) Study Investigators, Wen X, et al. Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy. Nephrol Dial Transplant 2014;29:1854–64. doi:10.1093/ndt/gfu051
38 Huang X, Dorhout Mees E, Vos P, et al. Everything we always wanted to know about furosemide but were afraid to ask. Am J Physiol Renal Physiol 2016;310:F958-71. doi:10.1152/ajprenal.00476.2015
39 Koyner JL, Davison DL, Brasha-Mitchell E, et al. Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity. J Am Soc Nephrol 2015;26:2023– 31. doi:10.1681/ASN.2014060535
40 Chawla LS, Davison DL, Brasha-Mitchell E, et al. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care 2013;17:R207. doi:10.1186/cc13015
41 Goldstein SL, Chawla LS. Renal angina. Clin J Am Soc Nephrol 2010;5:943–9. doi:10.2215/CJN.07201009
42 Basu RK, Zappitelli M, Brunner L, et al. Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int 2014;85:659–67. doi:10.1038/ki.2013.349
43 Basu RK, Wang Y, Wong HR, et al. Incorporation of biomarkers with the renal angina index for prediction of severe AKI in critically ill children. Clin J Am Soc Nephrol 2014;9:654–62. doi:10.2215/CJN.09720913
44 Cruz DN, Ferrer-Nadal A, Piccinni P, et al. Utilization of small changes in serum creatinine with clinical risk factors to assess the risk of AKI in critically lll adults. Clin J Am Soc Nephrol 2014;9:663–72. doi:10.2215/CJN.05190513
45 Asada T, Aoki Y, Sugiyama T, et al. Organ System Network Disruption in Nonsurvivors of Critically Ill Patients. Crit Care Med 2016;44:83–90. doi:10.1097/CCM.0000000000001354
46 Hayase N, Yamamoto M, Asada T, et al. Association of Heart Rate with N- Terminal Pro-B-Type Natriuretic Peptide in Septic Patients: A Prospective Observational Cohort Study. Shock 2016;46:642–8. doi:10.1097/SHK.0000000000000673
47 Isshiki R, Asada T, Sato D, et al. Association of Urinary Neutrophil Gelatinase- Associated Lipocalin With Long-Term Renal Outcomes in ICU Survivors: A Retrospective Observational Cohort Study. Shock 2016;46:44–51. doi:10.1097/SHK.0000000000000580
48 Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985;13. doi:10.1097/00003246- 198510000-00009
49 Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530–8. doi:10.1007/s00134-003-1662-x
50 Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982–92. doi:10.1053/j.ajkd.2008.12.034
51 Dent CL, Ma Q, Dastrala S, et al. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 2007;11:R127. doi:10.1186/cc6192
52 Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839–43. doi:10.1148/radiology.148.3.6878708
53 DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837–45.
54 Peerapornratana S, Mahamitra N, Srisawat N. 112 OUTCOMES OF RENAL REPLACEMENT THERAPY IN INTENSIVE CARE UNITS IN THAILAND. Kidney Int Reports 2017;2:S16. doi:10.1016/j.ekir.2017.06.060
55 Koyner JL, Adhikari R, Edelson DP, et al. Development of a Multicenter Ward- Based AKI Prediction Model. Clin J Am Soc Nephrol 2016;11:1935–43. doi:10.2215/CJN.00280116
56 Flechet M, Guiza F, Schetz M, et al. AKIpredictor, an online prognostic calculator for acute kidney injury in adult critically ill patients: development, validation and comparison to serum neutrophil gelatinase-associated lipocalin. Intensive Care Med 2017;43:764–73. doi:10.1007/s00134-017-4678-3
57 Section 3: Prevention and Treatment of AKI. Kidney Int Suppl 2012;2:37–68. doi:10.1038/kisup.2011.33
58 Summary of Recommendation Statements. Kidney Int Suppl 2012;2:8–12. doi:10.1038/kisup.2012.7
59 Murray PT, Mehta RL, Shaw A, et al. Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int. 2014;85:513–21. doi:10.1038/ki.2013.374
60 Mehta RL. Biomarker explorations in acute kidney injury: the journey continues. Kidney Int 2011;80:332–4. doi:10.1038/ki.2011.181
61 Goldstein SL. The Renal Angina Index to Predict Acute Kidney Injury: Are Adults Just Large Children? Kidney Int. reports. 2018;3:516–8. doi:10.1016/j.ekir.2018.03.004
62 Cordemans C, De Laet I, Van Regenmortel N, et al. Aiming for a negative fluid balance in patients with acute lung injury and increased intra-abdominal pressure: a pilot study looking at the effects of PAL-treatment. Ann Intensive Care 2012;2 Suppl 1:S15. doi:10.1186/2110-5820-2-S1-S15
63 Martin GS, Moss M, Wheeler AP, et al. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 2005;33:1681–7.
64 Lumlertgul N, Peerapornratana S, Trakarnvanich T, et al. Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial). Crit Care 2018;22:101. doi:10.1186/s13054-018-2021-1
65 Yamashita T, Doi K, Hamasaki Y, et al. Evaluation of urinary tissue inhibitor of metalloproteinase-2 in acute kidney injury: a prospective observational study. Crit Care 2014;18:716. doi:10.1186/s13054-014-0716-5
66 Menon S, Goldstein SL, Mottes T, et al. Urinary biomarker incorporation into the renal angina index early in intensive care unit admission optimizes acute kidney injury prediction in critically ill children: a prospective cohort study. Nephrol Dial Transplant 2016;31:586–94. doi:10.1093/ndt/gfv457
67 Vanmassenhove J, Vanholder R, Nagler E, et al. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant 2013;28:254–73. doi:10.1093/ndt/gfs380
論文の公開元へ
